Eleni Fyta
Overview
Explore the profile of Eleni Fyta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kyriakoulis K, Trontzas I, Kyriakoulis I, Terentes-Printzios D, Papageorgiou N, Fyta E, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(2):54.
PMID: 39077423
Background: Coronavirus disease 2019 (COVID-19) had a major impact on healthcare systems worldwide. During the early phase of the pandemic many elective procedures were postponed. At the same time, the...
2.
Kyriakoulis K, Kyriakoulis I, Trontzas I, Syrigos N, Kyprianou I, Fyta E, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(12):404.
PMID: 39076653
Background: Cardiac injury (CI) is not a rare condition among hospitalized patients with coronavirus disease 2019 (COVID-19). Its prognostic value has been extensively reported through the literature, mainly in the...
3.
Panagiotou E, Charpidou A, Fyta E, Nikolaidou V, Stournara L, Syrigos A, et al.
CNS Oncol
. 2023 May;
12(3):CNS98.
PMID: 37140173
Radiation-induced brain necrosis (RIBN) is a common adverse event from radiation therapy. We present a case of a 56-year-old man, diagnosed with non-small-cell lung cancer with brain metastases 2 years...
4.
Goumas G, Syrigos N, Fyta E, Dardavesis T, Simou E
Anticancer Res
. 2023 Jan;
43(2):773-779.
PMID: 36697067
The aim of the present review was to extend research by reviewing international research regarding the communication between oncologists and oncology patients and the communication of bad news to oncology...
5.
Grenzelia M, Zygogianni A, Grapsa D, Maragkoudakis E, Fyta E, Charpidou A, et al.
Cancer Diagn Progn
. 2022 Nov;
2(6):609-619.
PMID: 36340461
Background/aim: Brain metastases (BMs) are common in patients with non-small cell lung cancer (NSCLC). Whole-brain radiotherapy (WBRT) with or without corticosteroid use has historically been the first choice for most...
6.
Tsagkouli S, Kyriakoulis I, Kyriakoulis K, Fyta E, Syrigos A, Bakakos P, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740491
Mesothelioma, a malignant neoplasm of mesothelial cells, has overall poor prognosis. Cell adhesion molecules (CAMs) are proteins that contribute to the immune response. In this study the clinical utility and...
7.
Syrigos N, Kollias A, Grapsa D, Fyta E, Kyriakoulis K, Vathiotis I, et al.
Vaccines (Basel)
. 2022 May;
10(5).
PMID: 35632501
This brief report examined the frequency and characteristics of a significant blood-pressure (BP) increase after Pfizer-BioNTech BNT162b2 vaccination among healthcare workers who were advised to measure their BP at home....
8.
Trontzas I, Vathiotis I, Economidou C, Petridou I, Gomatou G, Grammoustianou M, et al.
Vaccines (Basel)
. 2022 Apr;
10(4).
PMID: 35455367
Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on their immunization status after vaccination. Methods: To evaluate...
9.
Kyriakoulis K, Kollias A, Diakos G, Trontzas I, Fyta E, Syrigos N, et al.
BMC Pulm Med
. 2021 Nov;
21(1):380.
PMID: 34809625
Background: Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated complications, involving complex autoimmune...